Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age
Clinical trial NCT02628444 · COMPLETED
Trial details
- NCT number
- NCT02628444
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-02
- Primary completion
- 2020-04-29
- Enrollment
- 1050
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.